Fig. 2From: Identification of characteristic metabolic panels for different stages of prostate cancer by 1H NMR-based metabolomics analysisROC curve analysis of the selected metabolites for discriminating PCa from BPH. The assessment of the diagnostic performance of A 3-HB; B alanine; C acetone; D tyrosine; E histidine; F a combination of five metabolites; G a merger of five metabolites with age and BMIBack to article page